{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:53:19Z","timestamp":1787320399021,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jacasi.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T18:29:57Z","timestamp":1632248997000},"page":"245-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society"],"prefix":"10.1016","volume":"1","author":[{"given":"Sayaka","family":"Funabashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsune","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakaoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jacasi.2021.07.004_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jacasi.2021.07.004_bib2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacasi.2021.07.004_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jacl.2017.12.014","article-title":"Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy","volume":"12","author":"Galema-Boers","year":"2018","journal-title":"J\u00a0Clin Lipidol"},{"issue":"10","key":"10.1016\/j.jacasi.2021.07.004_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.jacasi.2021.07.004_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2021.07.004_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-7-7","article-title":"Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia","volume":"7","author":"Zech","year":"2008","journal-title":"Lipids Health Dis"},{"issue":"16","key":"10.1016\/j.jacasi.2021.07.004_bib7","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Joint ESC\/ACCF\/AHA\/WHF Task Force for Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacasi.2021.07.004_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacasi.2021.07.004_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.atherosclerosis.2018.06.856","article-title":"Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study","volume":"277","author":"Harada-Shiba","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2021.07.004_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2021.07.004_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by modeling marginal distributions","volume":"84","author":"Wei","year":"1989","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"21","key":"10.1016\/j.jacasi.2021.07.004_bib12","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/sim.4780132105","article-title":"Cox regression analysis of multivariate failure time data: the marginal approach","volume":"13","author":"Lin","year":"1994","journal-title":"Stat Med"},{"key":"10.1016\/j.jacasi.2021.07.004_bib13","series-title":"STATA survival analysis reference manual release 17","first-page":"69","year":"2021"},{"key":"10.1016\/j.jacasi.2021.07.004_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2018.11.014","article-title":"Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register","volume":"281","author":"Humphries","year":"2019","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.jacasi.2021.07.004_bib15","article-title":"Trajectories of blood lipid concentrations over the adult life course and risk of cardiovascular disease and all-cause mortality: observations from the Framingham Study Over 35 Years","volume":"8","author":"Duncan","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"32","key":"10.1016\/j.jacasi.2021.07.004_bib16","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease, 1: evidence from genetic, epidemiologic, and clinical studies: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacasi.2021.07.004_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5551\/jat.11536","article-title":"Defining patients at extremely high risk for coronary artery disease in heterozygous familial hypercholesterolemia","volume":"19","author":"Sugisawa","year":"2012","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacasi.2021.07.004_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2019.10.010","article-title":"Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemia","volume":"291","author":"Cao","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2021.07.004_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2017.03.021","article-title":"Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease","volume":"260","author":"Li","year":"2017","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.jacasi.2021.07.004_bib20","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.jacasi.2021.07.004_bib21","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1194\/jlr.P030890","article-title":"Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions","volume":"53","author":"van Dijk","year":"2012","journal-title":"J\u00a0Lipid Res"},{"issue":"5","key":"10.1016\/j.jacasi.2021.07.004_bib22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.ATV.0000218507.95149.42","article-title":"Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia","volume":"26","author":"Junyent","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jacasi.2021.07.004_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcm.2005.06.004","article-title":"Formation of dysfunctional high-density lipoprotein by myeloperoxidase","volume":"15","author":"Nicholls","year":"2005","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jacasi.2021.07.004_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/ATVBAHA.115.306665","article-title":"Association between cholesterol efflux capacity and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia","volume":"36","author":"Ogura","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.jacasi.2021.07.004_bib25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamacardio.2020.2314","article-title":"Association of bempedoic acid administration with atherogenic lipid levels in phase 3 randomized clinical trials of patients with hypercholesterolemia","volume":"5","author":"Banach","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacasi.2021.07.004_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2018.04.007","article-title":"Remnant-like particles and coronary artery disease in familial hypercholesterolemia","volume":"482","author":"Tada","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.jacasi.2021.07.004_bib27","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacasi.2021.07.004_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacasi.2021.07.004_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2015.08.033","article-title":"Clinical features of familial hypercholesterolemia in Korea: predictors of pathogenic mutations and coronary artery disease\u2014a study supported by the Korean Society of Lipidology and Atherosclerosis","volume":"243","author":"Shin","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacasi.2021.07.004_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2019.08.004","article-title":"Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients","volume":"289","author":"Hori","year":"2019","journal-title":"Atherosclerosis"},{"issue":"8962","key":"10.1016\/j.jacasi.2021.07.004_bib31","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(95)92627-5","article-title":"Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia","volume":"345","author":"Nohara","year":"1995","journal-title":"Lancet"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374721000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374721000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:57:07Z","timestamp":1757411827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374721000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2772374721000739"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2021.07.004","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}